Bausch + Lomb to name Brent Saunders as CEO - WSJ (updated)

Bausch Health Companies

15/02/2023 10:50

(Adds background on Brent Saunders)
       Feb 15 (Reuters) - Eye-care company Bausch + Lomb Corp
 BLCO.TO  is expected to name Brent Saunders, the former chief
executive of Allergan, as its CEO and chairman of board, the
Wall Street Journal reported on Wednesday, citing people
familiar with the matter.
    The leadership change could be announced as soon as
Wednesday, according to the report.
    Bausch + Lomb is in the process of being spun out from
Bausch Health Companies  BHC.TO , which was formerly known as
Valeant.
        Brent Saunders served as the CEO of Allergan until it
was bought out by AbbVie Inc  ABBV.N  for $63 billion in 2020. 
    Bausch + Lomb did not immediately respond to a Reuters
request for comment. 
 (Reporting by Maria Ponnezhath, Manas Mishra and Raghav Mahobe
in Bengaluru; Editing by Sherry Jacob-Phillips)
 ((Maria.Ponnezhath@thomsonreuters.com; +91 8061822749;))